Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Transcranial Magnetic Stimulation Device Gets Drafted By Army

This article was originally published in The Gray Sheet

Executive Summary

Five months into the launch of Neuronetics' NeuroStar transcranial magnetic stimulation (TMS) therapy device to treat depression, a Walter Reed Army Medical Center psychiatrist is learning the ins and outs of using the technology on patients

You may also be interested in...



Device Companies Look Far and Wide for New Capital

The global recession that struck last September drove many device investors into hiding. This left a barren financial landscape for device companies to subsist on. But some are finding the funds they need, and they're sharing their survival stories.

Device Companies Look Far and Wide for New Capital

The global recession that struck last September drove many device investors into hiding. This left a barren financial landscape for device companies to subsist on. But some are finding the funds they need, and they're sharing their survival stories.

Neuronetics Overcomes Negative Panel Review To Earn Clearance For NeuroStar

FDA cleared Neuronetics' NeuroStar transcranial magnetic stimulation system for drug-resistant depression, despite a negative advisory panel review, based on a pivotal study subset analysis

Related Content

Topics

UsernamePublicRestriction

Register

MT027198

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel